2026. DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients with CNS Glial Tumors. First Results. Voprosy onkologii. 72, 2 (May 2026), OF-2504. DOI:https://doi.org/10.37469/0507-3758-2026-72-2-OF-2504.